Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for selective modification in drug design, making it valuable in medicinal chemistry research. Commonly employed in coupling reactions to introduce the 6-bromopyridin-2-yl piperazine moiety into larger molecules, enhancing target binding and pharmacokinetic properties. Also utilized in the preparation of receptor agonists and antagonists for neurological and inflammatory disorders.